Description
Application Department
The analyzer can be widely applied to clinical departments including Cardiology Dept., Clinical Laboratory, Emergency Dept., ICU, Oncology Dept., Nephrology Dept., Pediatrics Dept., Endocrinology Dept., Gynecology Dept., Respiratory Dept., Gastroenterology Dept., Urology Dept. etc.
Features
- Portable Design : Small in size (250 x 250 x 120mm); Light in weight (1.8kg)
- Multiplex Test Items : Cardiac marker; Inflammation monitoring; Diabetes; Fertility; Renal function etc.
- Easy to Use : Ready-to-use cassette, one-step test, automatic print, quantitative result
- Reliable Performance : CV=1%; r=0.990
- LIS and HIS Connectivity
Technical Data
| Assay Method | Lateral Flow Chromatography (Colloidal Gold) |
| Test Result | Quantitative |
| Language | English/Chinese (Spanish, French, German, Russian, Arabic, Vietnamese etc. are under developing) |
| Display | 5.6 Inch Touch Screen; Resolution 640×480 |
| Printer | Internal Thermal Printer |
| Working Environment | Temperature – +15¥- 35¥ Relative humidity – 10% – 85% Air pressure – 70.0kPa – 106.0kPa” |
| Power Supply | AC 100 ∼ 240V, 50 ∼ 60 Hz |
| Data Storage | 10,000 results can be saved |
| Dimensions | Height 120mm Width 250mm Length 250mm |
| Weight | 1.8KG |
Test Items
| Cat.# | Test Item | Disease | Measuring Range | Sample | Cut ∼ off Value | Reaction Time |
|---|---|---|---|---|---|---|
| CG 1001 | Troponin I (cTnI) | Myocardial Infarction | 0.5 ∼ 50.0ng/ml | S/P/W.B | 0.5ng/ml | 15min |
| CG 1002 | NT – proBNP | Heart failure | 100 ∼ 35000pg/ml | S/P/W.B | 300pg/ml | 15min |
| CG 1003 | hs – CRP | Cardiovascular inflammatory diseases; Inflammatory disorders | 0.5 ∼ 200.0mg/L | S/P/W.B/ fingertip blood | 3mg/L 10mg/L | 90s |
| CG 1004 | NT – proBNP / cTnI | Heart failure; Acute coronary syndrome | 100 ∼ 12000pg/ml 0.5 ∼ 50ng/ml | S/P/W.B | 300pg/ml 0.5ng/ml | 18min |
| CG 1005 | CK – MB / cTnI / Myo | Myocardial injury | 2.5 ∼ 80.0ng/ml 0.5 ∼ 50.0ng/ml 30 ∼ 600ng/ml | S/P/W.B | 5ng/ml 0.5ng/ml 70ng/ml | 15min |
| CG 1006 | D – Dimer | Venous thromboembolism; Pulmonary embolism | 0.1 ∼ 10.0mg/L | P/W.B | 0.5mg/L | 7min |
| CG 1007 | Procalcitonin (PCT) | Sepsis; Septic shock | 0.1 ∼ 50ng/ml | S/P/W.B | 0.1ng/ml | 15min |
| CG 1008 | CysC | Early diagnosis of kidney disease; Detection of kidney damage for surgery patients | 0.5 ∼ 10.0mg/L | S/P/W.B | 0.51 ∼ 1.09 mg/L | 3min |
| CG 1009 | mAib | Early diagnosis and evaluation of diabetic nephropathy | 10 ∼ 200mg/L | Urine | 20mg/L | 3min |
| CG 1010 | NGAL | The best indicator of early renal injury | 50 ∼ 5000ng/m | S/P/W.B/Urine | Blood:200ng/ml Urine:100ng/ml | 10min |
| CG 1011 | β – MG | Kidney damage for diabetic & hypertensive patients | 0.5 ∼ 20.0mg/L | S/P/W.B | 0.8 ∼ 3.0 mg/L | 3min |
| CG 1012 | CK – MB / cTnI | Myocardinal injury | 2.5 ∼ 80.0ng/ml 0.5 ∼ 50.0ng/ml | S/P/W.B | 5ng/ml 0.5ng/ml | 15min |
| CG 1013 | β HCG | Pregnancy early test | 25 ∼ 10000mIU/ml | S | 25mIU/ml | 10min |
| CG 1017 | HbA1c | Diabetes mellitus | 2% ∼ 14% | W.B | 3.8% ∼ 5.8% | 3min |
| CG 1018 | CK – MB | Myocardial injury | 2.5 ∼ 80.0ng/ml | S/P/W.B | 5ng/ml | 15min |
| CG 1024 | TSH | Screening, Clinical Diagnosis, Prognosis & Therapeutic Effect evaluation of Thyroid diseases | 0.05μIU/ml ∼ 50.00μIU/ml | S/P/W.B | 0.27 μIU/ml ∼ 4.20 μIU/ml | 15min |
